Sun Pharmaceutical Industries has received National Stock Exchange’s (NSE) approval to merge ‘specified therapeutic and investment’ business of its subsidiary into itself. As per norms, companies seeking to execute merger or de-merger strategies need to obtain a 'no-objection certificate' from stock exchanges.
In November 2013, the company already received its board’s approval to transfer ‘specified therapeutic and investment’ business, a part of Sun Pharma Global FZE, into itself.
Sun Pharmaceutical Industries is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.
